Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT AMYLYX PHARMACEUTICALS, INC.

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX)
Listen to this Section


$13.29
-1.0200 ( -7.13% ) 815.1K

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.

Market Data


Open $13.29
Previous Close $14.31
Volume 815.1K
Market Cap $1.47B
Day Range $13.26 - $14.42
52 Week Range $4.76 - $18.61
Shares Outstanding 111.19M
Change % -7.13%
Net Change ▼ -1.0200
Insider Ownership 0.00%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2022
CountryUnited States
UnderwriterGoldman Sachs, Leerink Partners, Evercore ISI, H.C. Wainwright, more

Insider Ownership Transactions

Total Amount Purchased: -3,245,337.00

Date Type Amount Purchased Purchaser
2024-02-28 Sale -36667.00 Mazzariello Gina
2024-02-28 Sale -40000.00 FRATES JAMES M
2024-02-28 Sale -126667.00 Cohen Joshua B
2024-02-28 Sale -126667.00 Klee Justin B.
2024-02-27 Sale -2838.00 Mazzariello Gina
2024-01-29 Sale -9100.00 MILNE GEORGE M JR
2024-01-18 Sale -94350.00 MILNE GEORGE M JR
2024-01-11 Sale -5841.00 Cohen Joshua B
2024-01-11 Sale -5841.00 Klee Justin B.
2024-01-11 Sale -2812.00 Yeramian Patrick D

SEC Filings


Form Type Description Pages Date
8-k 8K-related 12 Nov 06, 2025
10-q Quarterly Reports 59 Nov 06, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Oct 02, 2025
8-k 8K-related 14 Sep 10, 2025
8-k 8K-related 12 Aug 27, 2025
4 Insider transactions 1 Aug 14, 2025

Latest News


× Before browsing our site, please accept our cookies policy